Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
04/2003
04/10/2003US20030069249 Analgesics; central nervous system disorders
04/10/2003US20030069245 Aids therapy
04/10/2003US20030069236 New benzoxazine derivatives useful as integrin receptor antagonists
04/10/2003US20030069234 CXCR3 antagonists
04/10/2003US20030069224 Non-nucleoside reverse transcriptase inhibitors
04/10/2003US20030069223 Peptidyl deformylase inhibitors used for inhibiting bacteria or preventing bacterial contamination of a cell culture medium
04/10/2003US20030069222 Used as anti-viral agents against the HIV-1 and HIV-2 viruses.
04/10/2003US20030069210 Especially imidazolyl- or 1,2,4-triazolyl- pyrimidine derivatives
04/10/2003US20030069140 Herbicides
04/10/2003CA2462647A1 6-membered unsaturated heterocyclic compounds useful for selective inhibition of the coagulation cascade
04/10/2003CA2462601A1 Prodrugs of substituted polycyclic compounds useful for selective inhibition of the coagulation cascade
04/10/2003CA2462305A1 6-membered heterocyclic compounds useful for selective inhibition of the coagulation cascade
04/10/2003CA2461381A1 Chroman derivatives as 5-hydroxytryptamine-6 ligands
04/10/2003CA2460594A1 Mch receptor antagonists
04/10/2003CA2457647A1 Benzimidazolidinone derivatives as muscarinic agents
04/09/2003EP1300398A1 Propane-1,3-dione derivatives
04/09/2003EP1300396A1 1,2-dihydropyridine compounds, process for preparation of the same and use thereof
04/09/2003EP1299383A1 Sulfonyl-pyrrolidine derivatives useful for the treatment of neurological disorders
04/09/2003EP1299382A1 Composition and antiviral activity of substituted indoleoxoacetic piperazine derivatives
04/09/2003EP1299381A1 Substituted quinazoline derivatives and their use as inhibitors
04/09/2003EP1299380A1 Indole derivatives useful for the treatment of cns disorders
04/09/2003EP1299364A1 Benzodiazepines as inhibitors of hpv e1 helicase
04/09/2003EP1299362A1 Selective melanin concentrating hormone-1 (mch1) receptor antagonists and uses thereof
04/09/2003EP1299356A1 Novel compounds
04/09/2003EP1001766B1 Compounds for the treatment of ccr5-mediated diseases
04/09/2003EP0946528B1 OXYGEN OR SULFUR CONTAINING 5-MEMBERED HETEROAROMATICS AS FACTOR Xa INHIBITORS
04/09/2003EP0873123B1 Inhibitors of protein isoprenyl transferases
04/09/2003EP0843663B1 4-aryl-thio-pyridin-2(1h)-ones, drugs containing same, and uses thereof for treating hiv-related diseases
04/09/2003EP0708768B1 Tri-substituted imidazoles having multiple therapeutic properties
04/09/2003CN1409710A Cyclopropyl-anellated 3-(4,5-dihydroisoxazol-3-yl)-substituted benzoylpyrazoles
04/09/2003CN1409708A 酪氨酸激酶抑制剂 Tyrosine kinase inhibitor
04/09/2003CN1409704A Heterocycle derivatives and drugs
04/09/2003CN1105114C Sulfonyl divalent aryl alpha-hydroxy-iso-hydroximic acid compounds
04/09/2003CN1105113C Fungicidal pyrimidinones
04/08/2003US6545158 Such as N-(3,5-dichloropyridin-4-yl)-2-(1-(4-fluorobenzyl)-5-hydroxyindol-3-yl)-2 -oxoacetamide; for treatment of eosinophil-related disorders and chronic obstructive pulmonary disease
04/08/2003US6545153 Anticholesterol agents; antilipemic agents
04/08/2003US6545038 Heterocyclic metalloprotease inhibitors
04/08/2003US6545037 Thromboxane A2 (TXA2) receptor and 5HT2 serotonergic receptor antagonists; 3-(6-(((4-chlorophenyl)sulphonyl)amino)-3-((2-(4-methyl-1 -piperazinyl)phenoxy)methyl)-5,6, 7,8-tetrahydro-1-naphthyl)propanoic acid for example
04/08/2003US6545025 Antiinflammatroy agents; antiallergens
04/08/2003US6545023 For treating rheumatoid arthritis; for examle, 1-(4-(4-fluorophenyl)piperidin-1-yl),3-(2-methoxy-4 -chlorobenzylaminocarbonyl),3-isopropyl-cyclopentane
04/08/2003US6545022 Treatment of epilepsy, faintness attacks, hypokinesia, cranial disorders, neurodegenerative disorders, depression, anxiety, panic, pain, neuropathological disorders, inflammatory diseases, and gastrointestinal disorders
04/08/2003US6545020 Farnesyl Protein transferase inhibitors with in vivo radiosensitizing properties
04/08/2003US6545009 Retinoid-related receptor function regulating agent
04/08/2003US6544990 Such as N-(4-chlorobenzyl)-8-(4-hydroxybut-1-ynyl)-1-methyl-6-(morpholin-4-ylmethyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide for treatment against herpes viruse; enzyme inhibitors
04/08/2003US6544987 Compounds, compositions, and methods for stimulating neuronal growth and elongation
04/08/2003US6544986 Such as 5-(N,N-dibenzyl)aminocarbonyl-2-pyridone; enzyme inhibitors; for treatment of Alzheimer's disease
04/08/2003US6544985 For therapy of acute and/or chronic neurological disorders such as psychosis, schizophrenia, Alzheimer's disease, cognitive disorders and memory deficits
04/08/2003US6544982 3-aryl-5-aminoisoxazole derivatives
04/08/2003US6544981 Anticoagulants, cardiovascular disorders
04/08/2003CA2224983C Triazole antifungal agents
04/08/2003CA2123548C Piperazine derivatives
04/07/2003WO2002032866A1 (4-acylaminopiperidin-1-yl) acetamides as neurokinin antagonists
04/03/2003WO2003027234A2 Small organic molecule regulators of cell proliferation
04/03/2003WO2003027107A1 Substituted 3-pyridyl oxazoles as c17,20 lyase inhibitors
04/03/2003WO2003027105A1 Substituted 3-pyridyl thiophenes as c17,20 lyase inhibitors
04/03/2003WO2003027102A1 3-(arylamino)methylene-1, 3-dihydro-2h-indol-2-ones as kinase inhibitors
04/03/2003WO2003027101A1 Substituted 3-pyridyl pyrroles and 3-pyridyl pyrazoles as c17,20 lyase inhibitors
04/03/2003WO2003027100A1 Substituted 3-pyridyl pyrimidines as c17,20 lyase inhibitors
04/03/2003WO2003027096A1 Substituted 3-pyridyl imidazoles as c17,20 lyase inhibitors
04/03/2003WO2003027095A1 Substituted 3-pyridyl tetrazoles as steroid c17,20 lyase inhibitors
04/03/2003WO2003027094A2 Substituted 3-pyridyl indoles and indazoles as c17,20 lyase inhibitors
04/03/2003WO2003027085A2 3-pyridyl or 4-isoquinolinyl thiazoles as c17,20 lyase inhibitors
04/03/2003WO2003027083A1 Bicyclo[3,1,0]hexane containing oxazolidinone antibiotic and derivatives thereof
04/03/2003WO2003027080A1 3-substituted-4-pyrimidone derivatives
04/03/2003WO2003027074A1 Pyrazole derivatives useful in the treatment of hyper-proliferative disorders
04/03/2003WO2003027068A2 Substituted amines for the treatment of neurological disorders
04/03/2003WO2003026666A1 2-phenylamino-4- (5-pyrazolylamino)-pyrimidine derivatives as kinase inhibitors, in particular, as src kinase inhibitors
04/03/2003WO2003026665A1 2-phenylamino-4-(5-pyrazolylamino)-pyrimidine derivatives as kinase inhibitors, in particular, src kinase inhibitors
04/03/2003WO2003026664A1 2-phenylamino-4- (5-pyrazolylamino) -pyramidine derivatives as kinase inhibitors, in particular, src kinase inhibitors
04/03/2003WO2003026652A1 Lactam-containing compounds and derivatives thereof as factor xa inhibitors
04/03/2003WO2003026650A1 3-(heteroarylamino)methylene-1,3-dihydro-2h-indol-2-ones as kinase inhibitors
04/03/2003WO2003026587A2 Compounds useful for treating hepatitus c virus
04/03/2003WO2003011859A3 Oxazolidinone derivatives as antibacterial agents
04/03/2003WO2003002531A3 Fluoropyrrolidines as dipeptidyl peptidase inhibitors
04/03/2003WO2003002530A3 Pyrrolidines as dipeptidyl peptidase inhibitors
04/03/2003WO2002102799A3 Pyrrolidine oxadiazole- and thiadiazole oxime derivatives being oxytocin receptor antagonists
04/03/2003US20030065219 Cyclization of an alcohol containing urea compound
04/03/2003US20030065179 Diabetic therapy
04/03/2003US20030065176 Anticoagulant; cardiovascular disorders
04/03/2003US20030065175 Novel heterocyclic compounds having antibacterial activity: process for their preparation and pharmaceutical compositions containing them
04/03/2003US20030065012 Estrogen receptor modulators
04/03/2003US20030065007 Analgesics; psychological disorders; antidepressants
04/03/2003US20030064997 Novel compounds
04/03/2003US20030064992 N-aryl (thio) anthranilic acid amide derivatives, their preparation and their use as VEGF receptor tyrosine kinase inhibitors
04/03/2003US20030064985 Prevent virus reproduction
04/03/2003US20030064980 Respiratory system disorders; antiinflammatory agents
04/03/2003US20030064977 Viricides
04/03/2003US20030064972 Using thiazolidinone compound
04/03/2003US20030064429 Generation of picornaviral viricides; prepare chemical intermediates, form ketoester, lyse enolate, acylate, recover viricide
04/03/2003CA2726702A1 Lactam-containing compounds and derivatives thereof as factor xa inhibitors
04/03/2003CA2461709A1 Small organic molecule regulators of cell proliferation
04/03/2003CA2461603A1 Substituted amines for the treatment of neurological disorders
04/03/2003CA2461363A1 Substituted 3-pyridyl indoles and indazoles as c17,20 lyase inhibitors
04/03/2003CA2461360A1 3-pyridyl or 4-isoquinolinyl thiazoles as c17,20 lyase inhibitors
04/03/2003CA2461128A1 Pyrazole derivatives useful in the treatment of hyper-proliferative disorders
04/03/2003CA2443410A1 Bicyclo[3,1,0]hexane containing oxazolidinone antibiotic and derivatives thereof
04/02/2003WO2002030891A1 Aliphatic nitrogenous five-membered ring compounds
04/02/2003EP1298127A1 Amino acid-n-carboxy anhydrides hvaing substituent at nitrogen
04/02/2003EP1298125A1 Substituted benzimidazole compounds and their use for the treatment of cancer
04/02/2003EP1297834A1 Inhibitor for enzyme having two divalent metal ions as active centers
1 ... 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 ... 647